The effects of short-term raloxifene therapy on fibrinolysis markers: TAFI, tPA, and PAI-1

Ozeren M., Karahan S. C., Ozgur M., Eminagaoglu S., Unsal M. A., Baytan S., ...More

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, vol.84, no.10, pp.987-991, 2005 (SCI-Expanded) identifier identifier identifier


Background. Markers of fibrinolysis, thrombin-activatable fibrinolysis inhibitor (TAFI), tissue-type plasminogen activator (tPA), and plasminogen activator inhibitor-1 (PAI-1) levels were studied for the evaluation of short-term effects of raloxifene administration in postmenopausal women.